If they could rejuvenate the current classes of antibiotics though as opposed to just looking at one drug then it would appear Genentech got a monster deal if they picked it all up for the cap of the licensing agreement ? Regardless though any money is good for the company and it's still many multipes of current value.
PYC Price at posting:
1.4¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)